Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-329340
Filing Date
2013-08-09
Accepted
2013-08-09 17:01:34
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d542887d10q.htm 10-Q 678570
2 EX-31.1 d542887dex311.htm EX-31.1 10548
3 EX-31.2 d542887dex312.htm EX-31.2 10549
4 EX-32.1 d542887dex321.htm EX-32.1 4940
  Complete submission text file 0001193125-13-329340.txt   8781713

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ampe-20130630.xml EX-101.INS 716730
6 XBRL TAXONOMY EXTENSION SCHEMA ampe-20130630.xsd EX-101.SCH 58646
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ampe-20130630_cal.xml EX-101.CAL 43261
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ampe-20130630_def.xml EX-101.DEF 244959
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ampe-20130630_lab.xml EX-101.LAB 437815
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ampe-20130630_pre.xml EX-101.PRE 328336
Mailing Address 5445 DTC PARKWAY SUITE 925 GREENWOOD VILLAGE CO 80111
Business Address 5445 DTC PARKWAY SUITE 925 GREENWOOD VILLAGE CO 80111 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 131027295
SIC: 2834 Pharmaceutical Preparations